EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-10.84%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$2.83B
AUM Growth
+$436M
(+18%)
Cap. Flow
+$746M
Cap. Flow
% of AUM
26.37%
Top 10 Holdings %
Top 10 Hldgs %
77.97%
Holding
321
New
50
Increased
109
Reduced
123
Closed
20
Top Buys
| 1 |
Alibaba
BABA
|
$339M |
| 2 |
JD.com
JD
|
$68.3M |
| 3 |
Baidu
BIDU
|
$65M |
| 4 |
Pinduoduo
PDD
|
$52.7M |
| 5 |
NetEase
NTES
|
$43.1M |
Top Sells
| 1 |
Apple
AAPL
|
$5.06M |
| 2 |
Microsoft
MSFT
|
$3.9M |
| 3 |
Tesla
TSLA
|
$3.02M |
| 4 |
United States Brent Oil Fund
BNO
|
$2.65M |
| 5 |
Invesco DB Oil Fund
DBO
|
$2.53M |
Sector Composition
| 1 | Consumer Discretionary | 60.57% |
| 2 | Communication Services | 21.3% |
| 3 | Technology | 8.28% |
| 4 | Healthcare | 2.43% |
| 5 | Real Estate | 1.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
ConocoPhillips
COP
$116B
| $210K | 0.01% |
+2,916
| New | +$210K |
|
252
West Pharmaceutical
WST
$18B
| $209K | 0.01% |
+445
| New | +$209K |
|
|
TPTX
253
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $208K | 0.01% |
+4,366
| New | +$208K |
|
254
Broadridge
BR
$29.4B
| $207K | 0.01% |
1,133
-119
| -10% | -$21.7K |
|
255
Monolithic Power Systems
MPWR
$41.5B
| $207K | 0.01% |
420
-55
| -12% | -$27.1K |
|
256
BioCryst Pharmaceuticals
BCRX
$1.74B
| $206K | 0.01% |
14,885
+3,536
| +31% | +$48.9K |
|
257
Fate Therapeutics
FATE
$116M
| $206K | 0.01% |
+3,528
| New | +$206K |
|
258
ResMed
RMD
$40.6B
| $205K | 0.01% |
+787
| New | +$205K |
|
259
Halozyme
HALO
$8.76B
| $202K | 0.01% |
+5,027
| New | +$202K |
|
260
TJX Companies
TJX
$155B
| $201K | 0.01% |
+2,651
| New | +$201K |
|
261
Hewlett Packard
HPE
$31B
| $200K | 0.01% |
12,712
-1,365
| -10% | -$21.5K |
|
262
Kymera Therapeutics
KYMR
$3.11B
| $200K | 0.01% |
+3,150
| New | +$200K |
|
263
Labcorp
LH
$23.2B
| $200K | 0.01% |
+741
| New | +$200K |
|
264
NetApp
NTAP
$23.7B
| $200K | 0.01% |
2,172
-228
| -10% | -$21K |
|
265
TG Therapeutics
TGTX
$5.11B
| $199K | 0.01% |
+10,466
| New | +$199K |
|
|
ISEE
266
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $198K | 0.01% |
+11,828
| New | +$198K |
|
267
Amicus Therapeutics
FOLD
$2.46B
| $195K | 0.01% |
16,869
+1,098
| +7% | +$12.7K |
|
|
BLUE
268
DELISTED
bluebird bio
BLUE
| $193K | 0.01% |
+968
| New | +$193K |
|
269
Exelixis
EXEL
$10.2B
| $189K | 0.01% |
+10,364
| New | +$189K |
|
270
Dynavax Technologies
DVAX
$1.18B
| $182K | 0.01% |
+12,946
| New | +$182K |
|
271
Ironwood Pharmaceuticals
IRWD
$188M
| $182K | 0.01% |
15,602
+1,472
| +10% | +$17.2K |
|
|
DCPH
272
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $175K | 0.01% |
+17,933
| New | +$175K |
|
|
VXRT
273
DELISTED
Vaxart
VXRT
| $174K | 0.01% |
27,743
+7,940
| +40% | +$49.8K |
|
|
AGEN
274
Agenus
AGEN
$138M
| $173K | 0.01% |
2,730
+1,379
| +102% | +$87.4K |
|
275
Heron Therapeutics
HRTX
$201M
| $168K | 0.01% |
18,367
+3,562
| +24% | +$32.6K |
|